✦ LIBER ✦

Metastatic Soft Tissue Sarcoma in Adults

✍ Scribed by Dr Ole S. Nielsen, Jean-Yves Blay, Ian R. Judson…

Book ID: 120840462
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2003
Tongue: English
Weight: 162 KB
Volume: 2
Category: Article
ISSN: 0099-7374
DOI: 10.2165/00024669-200302030-00005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

866 Combination of doxorubicin/ifosfamid

866 Combination of doxorubicin/ifosfamide ± G-CSF in adult metastatic soft tissue sarcoma (STS)

✍ H.J. Weh; M. de Wit; D.K. Hossfeld 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 313 KB

Phase II trial of edatrexate in adult pa

Phase II trial of edatrexate in adult patients with metastatic soft tissue sarcomas, an Eastern Cooperative Oncology Group (ECOG) final report

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

695 An EORTC phase I study to determine

695 An EORTC phase I study to determine the safety of combined caelyx and ifosfamide in previously untreated adult patients with advanced or metastatic soft tissues sarcomas

✍ O.S. Nielsen; P. Reichardt; D. Pink; J. Lindegaard; S. Daugaard; C. Hermans; M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Dose-intensive chemotherapy with growth

Dose-intensive chemotherapy with growth factor or autologous bone marrow/stem cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma : A systematic review

✍ Shailendra Verma; Jawaid Younus; Denise Stys-Norman; Adam E. Haynes; Martin Blac 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

## Abstract A systematic review was performed to determine whether first‐line dose‐intensive chemotherapy supported by growth factor or autologous bone marrow/stem cell transplantation improves response rate, time‐to‐disease progression, or survival compared with standard‐dose chemotherapy in patie

1188 ORAL Final data of the EORTC phase

1188 ORAL Final data of the EORTC phase 1 study determining safety of Caelyx in combination with lfosfamide in previously untreated adult patients with advanced or metastatic soft tissues sarcomas

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Phase 1 European Organisation for Resear

Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx®) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas

✍ O.S. Nielsen; P. Reichardt; T.B. Christensen; D. Pink; S. Daugaard; C. Hermans; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 133 KB